Charles River Laboratories is continuing its run of layoffs by announcing the closure of its cell therapy contract development and manufacturing organization (CDMO) site in Hanover, Maryland that will ...
StockStory.org on MSN
Charles River Laboratories (CRL): Buy, sell, or hold post Q3 earnings?
Charles River Laboratories has had an impressive run over the past six months as its shares have beaten the S&P 500 by 20.5%.
Business: Charles River Laboratories is an early-stage contract research company. The company engages in laboratory animal medicine and science (research model technologies), and it has developed a ...
News-Medical.Net on MSN
Synthace collaborates with Charles River to offer the global pharma industry more robust, faster and cost-effective assays
Synthace, the leader in software and services for assay development, today announced a collaboration with Charles River ...
Swimmers were scheduled to take their annual dive into Boston's Charles River on Sunday. But due to elevated bacteria levels, the event dubbed "City Splash" has been canceled. Organizers had already ...
WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (CRL) today announced that four new directors will join its Board of Directors and that four long-time members of ...
Activist Commentary: Elliott is a very successful and astute activist investor. The firm's team includes analysts from leading tech private equity firms, engineers, operating partners – former ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results